December 15, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) To PRESENT AT WACHOVIA SECURITIES 10 FOR ‘O5 BIOTECH CONFERENCE

December 8, 2004 (download PDF)
Cypress Bioscience Inc. Completes Enrollment of Phase III Milnacipran Clinical Trial Results Expected Fall 2005

December 7, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT FIRST ALBANY CAPITAL ANNUAL GROWTH CONFERENCE

November 30, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT LAZARD LIFE SCIENCES CONFERENCE

November 18, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT GRANITE FINANCIAL GROUP HEALTHCARE INVESTORS CONFERENCE

November 9, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES THIRD QUARTER 2004 RESULTS AND COMMENCEMENT OF SECOND PHASE III TRIAL

November 8, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT CIBC WORLD MARKETS HEALTHCARE CONFERENCE

October 26, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT RODMAN & RENSHAW TECHVEST CONFERENCE

October 11, 2004 (download PDF)
Cypress' "Pain Assessment in Patients with Fibromyalgia Syndrome: A Consideration of Methods for Clinical Trials" Published in Clinical Journal of Pain

September 28, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE

September 20, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) APPOINTS NEW BOARD MEMBERS

September 9, 2004 (download PDF)
Cypress Bioscience Inc. and Forest Laboratories, Inc. TO COMMENCE THE SECOND PHASE III CLINICAL TRIAL FOR MILNACIPRAN IN THE FOURTH QUARTER

September 8, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT BIOCENTURY NEWSMAKERS CONFERENCE

August 9, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES SECOND QUARTER 2004 RESULTS

August 3, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) DRUG MILNACIPRAN HIGHLIGHTED IN TODAY'S WALL STREET JOURNAL FEATURE ON FMS

July 20, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) ANNOUNCES NEW MILNACIPRAN MANUFACTURING FACILITY IN FRANCE

June 21, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) PHASE II MILNACIPRAN DATA PRESENTED AT CINP CONGRESS IN PARIS

June 9, 2004 (download PDF)
Cypress Bioscience Inc. LISTED ON CHICAGO BOARD OPTIONS EXCHANGE

May 18, 2004 (download PDF)
Cypress Bioscience Inc. ADDED TO NASDAQ BIOTECHNOLOGY INDEX

May 17, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES FIRST QUARTER 2004 RESULTS

May 11, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT RODMAN & RENSHAW TECHVEST GLOBAL HEALTHCARE CONFERENCE

May 4, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT SMITH BARNEY CITIGROUP 2004 SMALL & MID-CAP CONFERENCE

May 3, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT THE DEUTSCHE BANK 29TH ANNUAL HEALTH CARE CONFERENCE

April 26, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) TO PRESENT AT THE CIBC ANNUAL BIOTECHNOLOGY & SPECIALTY PHARMACEUTICAL CONFERENCE

April 7, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION

April 2, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES PRICING OF COMMON STOCK IN PUBLIC OFFERING

March 29, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES PUBLIC OFFERING OF 5 MILLION SHARES OF COMMON STOCK

March 29, 2004 (download PDF)
Cypress Bioscience Inc. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR END 2003 RESULTS

March 8, 2004 (download PDF)
Cypress Bioscience Inc.(NASDAQ: CYPB) TO PRESENT AT THE SG COWEN 24TH ANNUAL HEALTHCARE CONFERENCE

March 4, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) to Present at the Jump Start to Products Conference

March 1, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) APPROVED FOR LISTING ON NASDAQ NATIONAL MARKET

February 19, 2004 (download PDF)
BIO CEO Panel to Address Faster, Lower Risk and Higher Return Approaches to Drug R&D at Annual BIO Industry CEO and Investor Conference

February 17, 2004 (download PDF)
Cypress Bioscience Inc. (NASDAQ: CYPB) to Present at the Roth Capital Partners 16th Annual Growth Stock Conference

January 26, 2004 (download PDF)
Cypress Bioscience, Inc. Licenses Collegium Pharmaceutical’s Milnacipran Patent Portfolio

January 9, 2004 (download PDF)
Cypress Bioscience, Inc., Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Development and Marketing Agreement for Milnacipran